Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19

Kevan L. Hartshorn

DOI: https://doi.org/10.3389/fcimb.2020.563850

IF: 6.073

2020-10-22

Frontiers in Cellular and Infection Microbiology

Abstract:There is abundant evidence that the innate immune response to influenza A virus (IAV) is highly complex and plays a key role in protection against IAV induced infection and illness. Unfortunately it also clear that aspects of innate immunity can lead to severe morbidity or mortality from IAV, including inflammatory lung injury, bacterial superinfection, and exacerbation of reactive airways disease. We review broadly the virus and host factors that result in adverse outcomes from IAV and show evidence that inflammatory responses can become damaging even apart from changes in viral replication <i>per se</i>, with special focus on the positive and adverse effects of neutrophils and monocytes. We then evaluate in detail the role of soluble innate inhibitors including surfactant protein D and antimicrobial peptides that have a potential dual capacity for down-regulating viral replication and also inhibiting excessive inflammatory responses and how these innate host factors could possibly be harnessed to treat IAV infection. Where appropriate we draw comparisons and contrasts the SARS-CoV viruses and IAV in an effort to point out where the extensive knowledge existing regarding severe IAV infection could help guide research into severe COVID 19 illness or vice versa.

immunology,microbiology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of the innate immune response during influenza A virus (IAV) infection and its similarities and differences with SARS - CoV - 2 infection, in the hope of obtaining inspiration for the treatment of COVID - 19 from the pathological mechanism of influenza virus infection.

Specifically, the paper focuses on the following aspects:

1. **The role of the innate immune response in influenza virus (IAV) infection**:
- The paper discusses in detail how the innate immune system plays a protective role in the early stage of influenza virus infection, and also points out that excessive inflammatory responses may lead to severe lung damage, secondary bacterial infections, and the exacerbation of respiratory diseases.
- It particularly emphasizes the dual roles of neutrophils and monocytes in host defense and harmful inflammation.

2. **The role of soluble innate inhibitors**:
- The paper explores the potential dual capabilities of soluble innate inhibitors such as surfactant protein D (SP - D) and antimicrobial peptides (such as LL - 37) in down - regulating virus replication and suppressing excessive inflammatory responses, and how these factors may be used for the treatment of influenza virus infection.

3. **Comparison between influenza virus (IAV) and SARS - CoV - 2**:
- By comparing the receptors, genome variation mechanisms, pathogenicity, and current antiviral therapies of influenza virus and SARS - CoV - 2, the paper looks for commonalities between the two in severe infections in order to guide the research and treatment of COVID - 19.

4. **Host factors leading to severe influenza virus infection**:
- The paper also discusses how host factors (such as genetic polymorphisms, chronic diseases, age, etc.) affect the severity of influenza virus infection, and points out that these factors may also be applicable to severe cases of COVID - 19.

In summary, the main purpose of this paper is to provide a reference for understanding the pathological mechanism of COVID - 19 through in - depth analysis of the innate immune response in influenza virus infection and to explore possible treatment strategies.